Research on disease-causing bacteria and how they spread. Covers waterborne bacteria, Lyme disease ecology, pathogenic genetics, and biofilm treatments.
A new study reviewing nearly 70 antimicrobial resistance studies suggests that aggressive treatment may not always be the best way to prevent resistant pathogens. The review found that varying drug dosages and treatment durations may affect resistance emergence, and moderate treatment could be a more effective strategy for some diseases.
Researchers found that MRSA biofilms form in joint fluid, making infections resistant to antibiotics. Pre-treatment with an enzyme can inhibit biofilm formation and increase bacterial susceptibility to antibiotics.
A new genetic test developed by scientists can detect canine fecal contamination in water, providing insights into the scale of the problem. The test identified 11 genetic markers common to most dog samples but absent from human ones, revealing the significant role dogs play in contaminating US waterways.
Sick mice produce specialized sugars to feed their gut microbiota and resist infection. Healthy recovery requires both L-fucose production and intact gut microbiota. The study suggests a potential role for L-fucose in preventing or tolerating Crohn's disease.
Researchers discover six unique states of pneumococcus bacteria, which can help develop tailored vaccines. The study found that each state has distinct DNA methylation patterns and alters gene expression, virulence, and disease severity.
Researchers found that plant seeds can be pre-colonized with beneficial bacteria, providing enhanced microbial protection. This discovery has significant implications for creating food-safe antimicrobials and understanding the importance of early colonization in establishing a healthy microbiome.
Researchers found that critically ill ICU patients lose almost all of their gut microbes and those left are mostly pathogenic, leading to life-threatening sepsis. The study suggests that minimizing antibiotic use and stabilizing remaining microbes could improve patient outcomes.
A research team from George Washington University has developed a new method for diagnosing pneumonia that uses DNA sequencing to identify bacterial pathogens. This approach could lead to more targeted and effective treatment, reducing healthcare costs and improving patient outcomes.
Researchers at Duke Medicine and Duke-NUS Graduate Medical School Singapore detail how Yersinia pestis bacteria hitchhike on immune cells in lymph nodes to spread the bubonic plague. New therapies that block host immune function show promise in preventing infection and improving survival.
Researchers at the University of Cambridge used a new technique to study the immune response to live Salmonella vaccines, finding they enhance the ability to prevent bacterial replication and spread. This is crucial for preventing conditions like bacteraemia, a major killer in Africa.
Researchers discovered that Streptococcus pneumoniae, the cause of most cases of bacterial pneumonia, can invade the heart and cause death of heart muscle cells. The study found that the pneumolysin toxin is responsible for this damage, and that an experimental vaccine formulation protected mice against cardiac invasion and heart damage.
Pathogens specifically target highly networked proteins with multiple functions to weaken their host. The plant model Arabidopsis thaliana shows that different pathogens attack the same proteins, suggesting a convergent targeting strategy.
A recent study published in Proceedings of the National Academy of Sciences reveals a vast array of bacteria living on tropical tree leaves, including over 400 species found on a single tree. The discovery has significant implications for understanding forest health, disease resistance, and the impact of climate change.
Research reveals that 57 Panamanian tree species have distinct bacterial communities on their leaves, with some bacteria linked to nitrogen fixing and methane consumption. The study provides a comparable understanding of the host attributes that explain patterns of microbial diversity in the plant microbiome.
Researchers at VIB/VUB have created a detailed three-dimensional image of the pores through which curli building blocks cross the bacterial cell wall, shedding light on biofilm formation. This breakthrough could lead to the development of small molecules that inhibit unwanted biofilm growth and pave the way for new applications in fiel...
Research in mice demonstrates that commensal bacteria enhance the immune system's ability to kill Klebsiella pneumoniae by boosting alveolar macrophage production of reactive oxygen molecules. The study suggests that signals from these beneficial bacteria play an active role in regulating immune function, even in the absence of infection.
Researchers have discovered Ixodes scapularis ticks in North Dakota, which vector Lyme disease, and are concerned about the potential spread of other tick-borne diseases. The ticks were found in six counties with established populations, raising concerns for public health.
Researchers identified lactic acid bacteria in honey that effectively counteracted severe human wound pathogens and persistent horse wounds. The bacteria produce a broad spectrum of antimicrobial compounds as needed, depending on the threat.
Researchers have developed a molecule that can silence the NDM-1 resistance gene in bacteria, restoring susceptibility to carbapenem antibiotics. This approach could be a viable strategy for treating resistant infections.
Scientists at Case Western Reserve University have found that a leaky gut is the underlying cause of non-AIDS complications in HIV-positive patients. The study, published in PLOS Pathogens, reveals that bacterial products seep out of the colon and trigger inflammation throughout the body.
Researchers at Kansas State University have discovered a family of proteins in Staphylococcus aureus that prevent neutrophils from functioning, leading to potential new treatments for staph infections and inflammatory diseases such as emphysema. The study sheds light on how the bacteria evade the immune system.
Scientists have found that Pseudomonas aeruginosa colonizes the nasopharynx before migrating to the lungs, leading to chronic infections. This new understanding provides an opportunity for developing treatments at the initial site of infection.
Recent research reveals that breast milk microbiomes are maintained by niche differentiation and dominant species, contradicting the traditional neutral theory. This finding has significant clinical implications for understanding mastitis and other diseases associated with breast milk.
Scientists discovered that Listeria uses RNA molecules to fine-tune protein production, allowing it to evade the immune system and resist antibiotics. By understanding this mechanism, researchers can develop targeted treatments to combat the life-threatening bacteria.
Researchers found that contaminated blood cultures can serve as diagnostic predictors for more targeted antibiotics. The study showed that highly resistant skin germs could indicate high mortality rates for the actual disease-causing bacteria.
Researchers have identified a unique class of materials, known as ionic liquids, that can neutralize biofilm-forming pathogens and deliver drugs through the skin. These materials are effective at disrupting biofilms and have minimal cytotoxicity effects on human cell lines.
A new study in mice finds that common gut bacteria protect against food allergies by inducing immune responses that prevent allergen exposure. Reintroducing Clostridia bacteria reverses sensitization to peanut allergens, indicating a unique protective role.
Scientists have identified Mycobacterium pinnipedii in Peru skeletons dating back at least 1000 years, revealing seals as a source of pre-Columbian tuberculosis. This finding sheds new light on the history of the disease in the Americas and has implications for future vaccine development.
A new study finds that ticks carrying Lyme disease are active throughout the year in Northwest California, posing a constant threat. The researchers' findings suggest that residents should take precautions year-round and know the symptoms of the disease.
Scientists have identified key regions of the Cwp84 enzyme that could be targeted by drugs to prevent Clostridium difficile colonization and toxin production. The research may lead to the development of a new type of anti-colonization inhibitor to treat C. difficile infection.
Researchers found that hoopoes' eggs change from bluish-grey to greenish-brown when exposed to preen gland secretion, which contains antimicrobial properties. This color change may serve as a signal about the mother bird's breeding quality.
Long antibiotic treatments are ineffective against slowly growing bacteria that persist in tissues, leading to ongoing disease. Slowly growing pathogens dominate treatment, posing a risk for relapse despite effective initial therapy.
Researchers found that the HIV virus's outer envelope is mistaken for bacterial antigens by the immune system, leading to ineffective antibodies. The study suggests a new hypothesis for how HIV vaccine development could be improved by targeting the gut flora.
Researchers discovered that a type of bacteria called Asaia blocks invasion of Wolbachia into mosquitoes' germlines, stopping the insects from transmitting Wolbachia to their offspring. This finding provides a potential answer to why some insect species are infected with Wolbachia while others are not.
Researchers discovered that a specific type of IgG2 antibody protects Pseudomonas aeruginosa by binding to extra-long sugars on the bacterial surface. This protection can lead to reduced antibacterial capacity and worsened disease outcomes in immunized individuals.
Research reveals Salmonella Typhi uses Vi capsular polysaccharide to evade neutrophil recognition, allowing it to disseminate throughout the body. The 'cloaking device' makes S. Typhi practically invisible to neutrophils.
A team of scientists has found that genetic changes in a bacterial pathogen may be caused by chance environmental events rather than genetic mutations. The study, published in PNAS, analyzed 149 genomes of Salmonella enterica serovar Paratyphi A and found that the pathogen had not changed dramatically over its 450-year history.
A team of scientists at Duke University has discovered a molecule that exploits the body's natural response to fungi and bacteria, using copper to kill microbial pathogens. The findings show promise for developing broad-spectrum antimicrobial agents with minimal harm to healthy cells.
Researchers at Virginia Commonwealth University School of Medicine have identified three surface proteins on the Anaplasma phagocytophilum bacterium that cause tick-transmitted disease. Targeting these proteins could lead to effective prevention and treatment, enabling the development of a vaccine.
Researchers have discovered how viruses called bacteriophages can be engineered to target and destroy a range of bacteria, including antibiotic-resistant C. diff, which causes fatal infections in hospitals. The study provides hope for developing an alternative to antibiotics.
A study found that HIV infection alters the relationship between semen bacteria and immune factors, affecting viral load. Semen bacterial diversity was reduced in infected men, but restored after treatment.
A new paper by UCSB researchers scrutinizes Naegleria fowleri, a heat-loving amoeba causing rare but fatal infections. The study highlights the distinction between sapronotic diseases and conventional infectious diseases.
Researchers discovered a small molecule produced by benign bacteria influences the behavior of Staphylococcus aureus, causing it to form biofilms. This finding could lead to new ways to manage bacterial communities and prevent infections.
The Leishmania parasite protects flies from bacterial disease, increasing their lifespan and survival rate. This finding highlights the potential unintended consequences of using bacterial controls to control leishmaniasis.
Researchers at the University of Delaware have identified a protein called HSP70 that helps stabilize NOD2, a key protein involved in Crohn's disease. This finding provides a possible pathway for developing an effective therapy for the inflammatory bowel disease.
Researchers at Washington State University found that cinnamon oil is effective in killing several strains of E. coli, including non-O157 STEC, which causes approximately 110,000 cases of illness annually. The oil can be incorporated into films and coatings for packaging meat and produce to eliminate microorganisms.
Researchers found a significant presence of Treponema denticola, an opportunistic pathogen, in Oetzi's DNA mixture, supporting computer tomography-based diagnosis of periodontitis. The analysis also revealed Clostridia-like bacteria in a dormant state, which could impact future conservation efforts.
A study from Brigham and Women's Hospital found that infection can significantly alter the gut microbiota, leading to new microbial signatures that may help detect early stages of inflammation. These findings could aid in better treatment and prevention of gastrointestinal infections and inflammation.
Scientists have discovered that gut immunity actively maintains healthy bacterial communities through precise regulation of immunoglobulin A production by regulatory T cells. This complex interplay between the immune system and bacteria is crucial for preventing autoimmune disorders associated with dysbiosis in the gut.
Researchers discover that P. gingivalis modifies its lipid A structure to evade host defenses and establish chronic infection, leading to persistent systemic low-grade inflammation. This mechanism contributes to the progression of atherosclerosis in blood vessels.
Researchers created nanopyramids made of DNA that can flag and kill bacteria, with a success rate of 65% for Staphylococcus aureus and 48% for Escherichia coli compared to traditional medicine. The innovation offers a new approach to delivering drugs directly into bacterial cells.
Researchers found genetically identical bacteria respond differently to sugars, exhibiting a wide range of behaviors. The study highlights the complexity of bacterial behaviors and their response to environmental conditions.
A new research unit at Goethe University Frankfurt aims to understand the molecular basis of multi-drug resistant Acinetobacter baumannii strains, a common and deadly nosocomial pathogen. The researchers will study the bacterium's biology, infection process, and resistance mechanisms using an interdisciplinary approach.
Researchers at the University of Liverpool discovered a mechanism by which Streptococcus pneumoniae switches from harmless commensal to pathogenic bacterium, triggered by T regulatory cells. This balance is crucial in preventing inflammation and disease.
Researchers discovered that foodborne pathogen Campylobacter jejuni can cause problems in chickens' gut and damage their feet and legs when they walk through contaminated excrement. The bacteria's impact varied among breeds, with one showing significant damage to the gut and developing diarrhea.
Researchers at ETH Zurich have developed a new approach for tuberculosis drugs, inspired by the bacteria-derived antibiotic pyridomycin. The new molecule is more stable and easier to produce synthetically, offering a potential solution to multidrug-resistant strains.
A study published in mBio found that Campylobacter jejuni, a foodborne pathogen, can cause disease in some breeds of chickens. The bacteria were previously thought to be harmless to birds.
Scientists expect progress in developing an effective TB vaccine, with Phase IIa clinical trials underway. The new vaccine aims to activate both killer and helper cells for improved immune response.
Researchers discovered Staphylococcus aureus creates biofilm streamers using a biological glue, which can rapidly clog up medical devices. The bacteria's ability to form these slimy structures is crucial in understanding the mechanism of infections associated with medical devices.
Researchers found that blocking the activation of five genes responsible for transporting fructose-asparagine could be a new strategy to fight Salmonella infections. The nutrient is composed of a sugar and amino acid, and its identification alone is unusual since it has never been discovered as a nutrient for any organism.